Human Corin Isoforms with Different Cytoplasmic Tails That Alter Cell Surface Targeting

od Qi, Xiaofei, Jiang, Jingjing, Zhu, Mingqing, Wu, Qingyu
Izdano 2011

Altered circulating T follicular helper cells in patients with chronic immune thrombocytopenia

od Dai, Lan, He, Linyan, Wang, Zhaoyue, Bai, Xia, He, Yang, Cao, Lijuan, Zhu, Mingqing, Ruan, Changgeng
izdano v Exp Ther Med (2018)

Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia

od Li, Jiaming, Wang, Zhaoyue, Dai, Lan, Cao, Lijuan, Su, Jian, Zhu, Mingqing, Yu, Ziqiang, Bai, Xia, Ruan, Changgeng
Izdano 2013

Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification

od Yan, Lingzhi, Ping, Nana, Zhu, Mingqing, Sun, Aining, Xue, Yongquan, Ruan, Changgeng, Drexler, Hans G., MacLeod, Roderick A. F., Wu, Depei, Chen, Suning
Izdano 2012

High Tim-3 expression on AML blasts could enhance chemotherapy sensitivity

od Xu, Liangjing, Xu, Jinge, Ma, Shoubao, Li, Xiaoli, Zhu, Mingqing, Chen, Suning, Han, Yue, Tang, Xiaowen, Fu, Zhengzheng, Qiu, Huiying, Yu, Jianhua, Wu, Depei, Wu, Xiaojin
izdano v Oncotarget (2017)

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia

od Tang, Xiaowen, Yang, Lin, Li, Zheng, Nalin, Ansel P, Dai, Haiping, Xu, Ting, Yin, Jia, You, Fengtao, Zhu, Mingqing, Shen, Wenhong, Chen, Guanghua, Zhu, Xiaming, Wu, Depei, Yu, Jianhua
izdano v Am J Cancer Res (2018)

First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia

od Tang, Xiaowen, Yang, Lin, Li, Zheng, Nalin, Ansel P, Dai, Haiping, Xu, Ting, Yin, Jia, You, Fengtao, Zhu, Mingqing, Shen, Wenhong, Chen, Guanghua, Zhu, Xiaming, Wu, Depei, Yu, Jianhua
izdano v Am J Cancer Res (2018)

Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma

od Yan, Lingzhi, Qu, Su, Shang, Jingjing, Shi, Xiaolan, Kang, Liqing, Xu, Nan, Zhu, Mingqing, Zhou, Jin, Jin, Song, Yao, Weiqin, Yao, Ying, Chen, Guanghua, Chang, Huirong, Zhu, Xiaming, Yu, Lei, Wu, Depei, Fu, Chengcheng
izdano v Cancer Med (2020)

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

od Cui, Qingya, Qian, Chongsheng, Xu, Nan, Kang, Liqing, Dai, Haiping, Cui, Wei, Song, Baoquan, Yin, Jia, Li, Zheng, Zhu, Xiaming, Qu, Changju, Liu, Tianhui, Shen, Wenhong, Zhu, Mingqing, Yu, Lei, Wu, Depei, Tang, Xiaowen
izdano v J Hematol Oncol (2021)

Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia

od Chen, Mengxing, Yan, Rong, Zhou, Kangxi, Li, Xiaodong, Zhang, Yang, Liu, Chunliang, Jiang, Mengxiao, Ye, Honglei, Meng, Xingjun, Pang, Ningbo, Zhao, Lili, Liu, Jun, Xiao, Weiling, Hu, Renping, Cui, Qingya, Zhong, Wei, Zhao, Yunxiao, Zhu, Mingqing, Lin, Anning, Ruan, Changgeng, Dai, Kesheng
izdano v Proc Natl Acad Sci U S A (2018)